Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status.
about
Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study.Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study.Pattern of distant recurrence according to the molecular subtypes in Korean women with breast cancerClinicopathologic characteristics and prognostic factors for HER2-positive patients with metastatic breast cancer in southern China.Hormone receptor status predicts the clinical outcome of human epidermal growth factor 2-positive metastatic breast cancer patients receiving trastuzumab therapy: a multicenter retrospective studyEffect of HER2 status on distant recurrence in early stage breast cancerHuman epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes?Breast cancer molecular subtypes and survival in a hospital-based sample in Puerto Rico.Trastuzumab improves locoregional control in HER2-positive breast cancer patients following adjuvant radiotherapy.The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival.Implications of different CA 15-3 levels according to breast cancer subtype at initial diagnosis of recurrent or metastatic breast cancer.Pattern of metastasis and outcome in patients with breast cancer.Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer.
P2860
Q33739253-7ECFDAE9-C77A-400F-960D-B1605B7D89BBQ33875853-DD233B11-4BFB-4147-9945-2D9A37B1CB08Q34240305-34E63B7D-D221-4E25-8DB1-A6EAF11079E8Q35777113-7D35938F-C9D8-4764-BA78-EA3E28022F41Q35829230-47C62E11-4362-465B-AD93-6411740265BEQ36288976-19CF7311-E923-48E7-ADFA-EAFAEE7851C1Q36530791-45489A10-6342-4A33-ABAC-445548E36664Q36551617-865550E2-9362-422D-AE80-53120F4CC3E8Q36977429-F50AEBC3-1EEB-47B8-A569-93408494214BQ37175884-2F71E086-E0A3-4EF1-A9BF-C4276ADD004FQ45757920-565617DA-1C4C-4365-9274-870A4EE5974EQ48000299-4CFB7340-9D15-4B1D-9A0B-444090C7927CQ54294135-C9211672-1F02-47F7-A623-77050F798064Q54353219-AEB2834E-746B-4C56-89EC-D9C77CA00421
P2860
Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Patterns of relapse and metast ...... g to estrogen receptor status.
@en
Patterns of relapse and metast ...... g to estrogen receptor status.
@nl
type
label
Patterns of relapse and metast ...... g to estrogen receptor status.
@en
Patterns of relapse and metast ...... g to estrogen receptor status.
@nl
prefLabel
Patterns of relapse and metast ...... g to estrogen receptor status.
@en
Patterns of relapse and metast ...... g to estrogen receptor status.
@nl
P2093
P1476
Patterns of relapse and metast ...... g to estrogen receptor status.
@en
P2093
Eun Yoon Cho
Jeong Eon Lee
Jin Seok Ahn
Jung-Hyun Yang
Seok Jin Nam
Soohyeon Lee
Yeon Hee Park
Yoon La Choi
Young-Hyuck Im
P2888
P304
P356
10.1007/S00280-009-1190-7
P577
2009-12-03T00:00:00Z